Bottom line
What is BMGAX's expense ratio?
BMGAX's expense ratio is 1.05%, or about $105 a year on every $10,000 invested. That is more expensive than 66% of mid-cap funds we track (median 0.88%). This share class also charges a front-end sales load of up to 5.25%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Sep 25, 2026
BMGAX fee table
| Net expense ratio | 1.05% |
|---|---|
| Gross expense ratio | 1.12% |
| Management fee | 0.64% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.23% |
| Fee waiver / reimbursement | -0.07% |
| Max front-end sales load | 5.25% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Sep 25, 2026
What BMGAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| BMGAX | $626 | $856 | $1,103 | $1,811 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.05% expense ratio costs roughly $57,900 in lost growth, versus about $49,300 for the median mid-cap fund (0.88%).